SMT201200064B - Composizioni per uso nel trattamento di sindromi mielodisplastiche - Google Patents

Composizioni per uso nel trattamento di sindromi mielodisplastiche

Info

Publication number
SMT201200064B
SMT201200064B SM201200064T SM201200064T SMT201200064B SM T201200064 B SMT201200064 B SM T201200064B SM 201200064 T SM201200064 T SM 201200064T SM 201200064 T SM201200064 T SM 201200064T SM T201200064 B SMT201200064 B SM T201200064B
Authority
SM
San Marino
Prior art keywords
compositions
treatment
myelodysplastic syndromes
myelodysplastic
syndromes
Prior art date
Application number
SM201200064T
Other languages
English (en)
Italian (it)
Inventor
Gail L Brown
Lixin Meng
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of SMT201200064B publication Critical patent/SMT201200064B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM201200064T 2010-06-07 2012-12-27 Composizioni per uso nel trattamento di sindromi mielodisplastiche SMT201200064B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35237410P 2010-06-07 2010-06-07
US13/108,756 US20110301199A1 (en) 2010-06-07 2011-05-16 Compositions and methods for treating myelodysplastic syndrome

Publications (1)

Publication Number Publication Date
SMT201200064B true SMT201200064B (it) 2013-03-08

Family

ID=44644899

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201200064T SMT201200064B (it) 2010-06-07 2012-12-27 Composizioni per uso nel trattamento di sindromi mielodisplastiche

Country Status (10)

Country Link
US (1) US20110301199A1 (pl)
EP (1) EP2392329B1 (pl)
JP (1) JP2012025734A (pl)
CN (1) CN102389564A (pl)
AU (1) AU2011202637A1 (pl)
CA (1) CA2742032A1 (pl)
DK (1) DK2392329T3 (pl)
ES (1) ES2396468T3 (pl)
PL (1) PL2392329T3 (pl)
SM (1) SMT201200064B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8759303B2 (en) * 2010-06-07 2014-06-24 Telik, Inc. Compositions and methods for treating myelodysplastic syndrome
CN109395058A (zh) * 2016-03-13 2019-03-01 曹帅 一种用于治疗骨髓增生、骨癌的药物组合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599903A (en) 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
US7189740B2 (en) * 2002-10-15 2007-03-13 Celgene Corporation Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes

Also Published As

Publication number Publication date
AU2011202637A1 (en) 2011-12-22
CN102389564A (zh) 2012-03-28
PL2392329T3 (pl) 2013-03-29
EP2392329A1 (en) 2011-12-07
US20110301199A1 (en) 2011-12-08
EP2392329B1 (en) 2012-10-03
JP2012025734A (ja) 2012-02-09
CA2742032A1 (en) 2011-12-07
ES2396468T3 (es) 2013-02-21
DK2392329T3 (da) 2013-01-02

Similar Documents

Publication Publication Date Title
SMT201500148B (it) Composizioni per uso nel trattamento di infezioni virali
SMT201700008B (it) Composizione farmaceutica
SMT201600350B (it) Composizioni farmaceutiche
SMT201400008B (it) Uso di betanecolo per il trattamento di xerostomia
BR112012031667A2 (pt) composição
DK2640893T4 (da) Sammensætninger
DK3246018T3 (da) Farmaceutisk sammensætning
BR112012032683A2 (pt) composição
DK2654736T3 (da) Hidtil ukendt farmaceutisk sammensætning
EE201300005A (et) Ravimkoostis
BRPI1009465A2 (pt) Formulação
BR112012030939A2 (pt) acessório dentário
BR112012032980A2 (pt) composição
DK2745849T3 (da) Polydeoxyribonukleotidsammensætning og anvendelser deraf
BR112013016223A2 (pt) películas e composições compreendendo as mesmas
DK2343051T3 (da) Anti-cancer formulering
FR2958537B1 (fr) Composition dentaire
BRPI1011036A2 (pt) uso
BR112013013786A2 (pt) composição de limpeza
CO6801722A2 (es) Composiciones farmacéuticas
BR112013014811A2 (pt) composição de tratamento de pano
FR2957252B1 (fr) Composition cosmetique
BR112013003275A2 (pt) composição de tratamento oral
DK2621517T4 (da) Sammensætning til anvendelse i behandlingen af infertilitet
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina